Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase III Study of Monolaurin Cream Therapy for Patients With Congenital Ichthyosis
This study is ongoing, but not recruiting participants.
Study NCT00004690   Information provided by FDA Office of Orphan Products Development
First Received: February 24, 2000   Last Updated: June 23, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Ichthyosis
More general conditions related to this trial
Congenital Abnormalities
Infant, Newborn, Diseases
Keratosis
Skin Abnormalities
Skin Diseases
Interventions listed in this trial
monolaurin cream
Additional drug interventions recognized in this trial
Monolaurin
More general drug interventions related to this trial
Cariostatic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Sponsors listed in this trial
FDA Office of Orphan Products Development
Cellegy Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services